Evidence map›Paper›PMID 39852676›Full record

ReviewTropical medicine and infectious disease2025

The Global Challenge of

Zubeiru Bukari, Toyin Emmanuel, Jude Woodward, Richard Ferguson, Martha Ezughara, Nikhil Darga, Bruno Silvester Lopes

Abstract readReview
In one paragraph

Review in Tropical medicine and infectious disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Surveillance of enteropathogenicJournal of medical microbiology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Pathogens (Basel, Switzerland) · 2026
    Article
  9. Review
  10. Whole-genome sequences ofMicrobiology resource announcements · 2026
    Article
  11. Phenotypic Resistance of Ciprofloxacin and Azithromycin ResistantbioRxiv : the preprint server for biology · 2026
    Article
  12. Detection and Characterization of ThermotolerantAntibiotics (Basel, Switzerland) · 2026
    Article
  13. Article
  14. Emerging Risk ofOpen forum infectious diseases · 2025
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Microplastics-AssistedFoods (Basel, Switzerland) · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Zubeiru BukariSchool of Health and Life Sciences, Teesside University, Middlesbrough TS1 3BX, UK.
Toyin EmmanuelSchool of Health and Life Sciences, Teesside University, Middlesbrough TS1 3BX, UK.
Jude WoodwardSchool of Health and Life Sciences, Teesside University, Middlesbrough TS1 3BX, UK.
Richard FergusonSchool of Health and Life Sciences, Teesside University, Middlesbrough TS1 3BX, UK.
Martha EzugharaSchool of Health and Life Sciences, Teesside University, Middlesbrough TS1 3BX, UK.
Nikhil DargaSchool of Health and Life Sciences, Teesside University, Middlesbrough TS1 3BX, UK.
Bruno Silvester LopesSchool of Health and Life Sciences, Teesside University, Middlesbrough TS1 3BX, UK.ORCID 0000-0002-1476-2108

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antimicrobial resistance (AMR) in

Indexed as

aminoglycosidesantimicrobial resistanceCampylobacterfluoroquinolonesinterventionsmacrolidestetracyclinestransmission

Identifiers

PMID39852676
PMCPMC11768457

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.